Stocks, Financial Models And AIDS: A Heady Cocktail To Combat A Virus
Thursday, October 13, 2011 - 12:31
in Mathematics & Economics
Number crunchers have never been much of nature lovers. Most venture capitalists, as it were, would rather be content, mulling over their wins and losses in the vagaries of business transactions of a life sciences company, than showering encomiums on the potential benefits of a technology that could potentially double up as a silver bullet for debilitating diseases such as diabetes, cancer or AIDS. read more